Adverse Events in Patients Initiated on Dabigatran Etexilate Therapy in a Pharmacist-Managed Anticoagulation Clinic

Pharmacy Practice - Spain
doi 10.4321/s1886-36552013000200005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Instituto de Salud Carlos III/BNCS/SciELO Espana

Related search

Comparison of Pharmacist Managed Anticoagulation With Usual Medical Care in a Family Medicine Clinic

BMC Family Practice
Family Practice
2011English

Implementation and Outcomes of a Pharmacist-Managed Clinical Video Telehealth Anticoagulation Clinic

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2015English

New Options With Dabigatran Etexilate in Anticoagulant Therapy

Vascular Health and Risk Management
2010English

Warfarin-Related Outcomes in Patients With Antiphospholipid Antibody Syndrome Managed in an Anticoagulation Clinic

Thrombosis and Haemostasis
Hematology
2006English

Impact of Pharmacist Led Anticoagulation Monitoring and Patient Education on Oral Anticoagulation Therapy With Acenocoumarol

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Two and Half Years With Dabigatran Etexilate in Neurological Units

Journal of Vascular Medicine & Surgery
2013English

Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients With Atrial Fibrillation: The IDEA Study

Clinical Drug Investigation
MedicinePharmacology
2019English

Comment On: “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia”

Drug Safety
ToxicologyPharmacology
2015English

Educating Patients in Self-Management of Epistaxis in an Anticoagulation Clinic

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy